Designer cannabinoids arrived like a second alphabet, each letter promising clarity, calm, or cosmic lift. Some — THCV, CBG, CBC — are old molecules finally getting their due. Others, like…
Cannabis legalization in 2025 is a patchwork of progress and paradox. Canada refines its mature market, Germany cautiously expands through clubs and pilots, and Mexico lingers in legal limbo. Worldwide,…
Federal cannabis policy under Trump is a study in contradictions. While he nods to state autonomy, his DOJ prosecutes possession on federal lands. Rescheduling offers research relief but not legalization.…
Congress’s recent budget agreement has sent shockwaves through the hemp sector, effectively banning most intoxicating hemp products such as Delta‑8 THC gummies, beverages, and vapes. Industry leaders warn this move…
Kamala Harris's nomination as the Democratic presidential candidate significantly boosts the chances of marijuana legalization in the U.S. Harris has evolved from opposing marijuana legalization to advocating for decriminalization and…
marijuana legalization in the United States
The landscape of marijuana legislation and research is rapidly evolving. This report synthesizes the latest developments in marijuana legalization, federal reclassification efforts, and emerging research findings. The information is drawn…
Washington, D.C. – The U.S. Drug Enforcement Administration (DEA) has initiated a process that could potentially reclassify marijuana, currently a Schedule I controlled substance, to a less restrictive category. This…
Oakland, CA – The Emerald Cup, California’s premier cannabis festival, is set to celebrate its 20th anniversary with a grand event that promises to be a transformative experience for the…
In a landmark move, the U.S. Drug Enforcement Administration (DEA) has announced plans to reclassify marijuana from a Schedule I to a Schedule III controlled substance. This significant policy shift,…
Professor 420